NEW YORK (GenomeWeb News) – Co-Diagnostics HBDC and Mentors International have inked an agreement to offer real-time PCR-based tests in developing nations at lower costs, they announced today.

Starting with a pilot program in Guatemala and an initial testing focus on tuberculosis, Co-Diagnostics HBDC will provide low-cost testing reagents, and Mentors will leverage its international network to create low-cost testing facilities. Mentors will identify machines that cost less and provide training to second-generation workers in its microfinancing program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.